HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew S C Rice Selected Research

Postherpetic Neuralgia

10/2021Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy.
11/2018Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysis.
1/2018Up-date on Clinical Management of Postherpetic Neuralgia and Mechanism-Based Treatment: New Options in Therapy.
2/2016Selective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studies.
10/2015Oral nonsteroidal anti-inflammatory drugs for neuropathic pain.
5/2014EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial.
4/2014Gabapentin for chronic neuropathic pain and fibromyalgia in adults.
11/2013Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews.
7/2005Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew S C Rice Research Topics

Disease

61Pain (Aches)
11/2022 - 03/2002
35Neuralgia (Stump Neuralgia)
01/2022 - 07/2005
11Peripheral Nervous System Diseases (PNS Diseases)
01/2022 - 04/2013
9Postherpetic Neuralgia
10/2021 - 07/2005
8Chronic Pain
01/2022 - 11/2013
8Hypersensitivity (Allergy)
01/2020 - 10/2007
6Diabetic Neuropathies (Diabetic Neuropathy)
01/2022 - 11/2013
6Inflammation (Inflammations)
01/2022 - 01/2002
3Wounds and Injuries (Trauma)
01/2022 - 04/2014
3Sleep Initiation and Maintenance Disorders (Insomnia)
01/2021 - 09/2014
3Polyneuropathies (Polyneuropathy)
01/2020 - 04/2014
3Leprosy (Hansen's Disease)
11/2019 - 03/2011
2Low Back Pain (Lumbago)
01/2022 - 10/2015
2Neoplasms (Cancer)
01/2021 - 01/2002
2Spinal Cord Injuries (Spinal Cord Injury)
01/2016 - 01/2014
2Fibromyalgia (Fibrositis)
04/2014 - 11/2013
2HIV Infections (HIV Infection)
04/2009 - 10/2007
2Hyperalgesia
12/2003 - 05/2002
1Reinjuries
01/2022
1Kinesiophobia
01/2022
1Mental Disorders (Mental Disorder)
01/2022
1Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
01/2020
1Substance-Related Disorders (Drug Abuse)
12/2018
1Sleepiness
04/2014
1Dizziness (Lightheadedness)
04/2014

Drug/Important Bio-Agent (IBA)

24Analgesics (Analgesic Drugs)IBA
11/2022 - 03/2002
16CannabinoidsIBA
01/2021 - 03/2002
10Pharmaceutical PreparationsIBA
11/2018 - 10/2007
8Gabapentin (Neurontin)FDA LinkGeneric
11/2018 - 10/2007
7EndocannabinoidsIBA
01/2021 - 03/2002
6NAD (NADH)IBA
01/2022 - 05/2016
4Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2017
4Morphine (MS Contin)FDA LinkGeneric
01/2020 - 10/2007
4Freund's AdjuvantIBA
01/2020 - 03/2009
4Pregabalin (Lyrica)FDA Link
11/2018 - 11/2013
4Amitriptyline (Elavil)FDA LinkGeneric
01/2017 - 10/2007
4Anticonvulsants (Antiepileptic Drugs)IBA
04/2014 - 01/2006
3Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2007
3Type 2 Angiotensin ReceptorIBA
10/2021 - 04/2014
3EMA400IBA
10/2021 - 05/2014
3palmidrolIBA
01/2021 - 12/2003
3Reverse Transcriptase InhibitorsIBA
01/2017 - 10/2007
3NucleosidesIBA
01/2017 - 10/2007
3Capsaicin (Zostrix)FDA Link
02/2015 - 03/2010
24-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2022 - 01/2021
2fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
01/2021 - 03/2009
2NeuropeptidesIBA
09/2019 - 11/2013
2Angiotensin II Type 2 Receptor BlockersIBA
02/2016 - 04/2014
2Stavudine (Zerit)FDA LinkGeneric
09/2013 - 04/2013
2Antidepressive Agents (Antidepressants)IBA
10/2009 - 01/2006
2Zalcitabine (Hivid)FDA Link
04/2009 - 10/2007
2Glycoproteins (Glycoprotein)IBA
12/2007 - 10/2007
2(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
12/2007 - 10/2007
2Nerve Growth Factor (NGF)IBA
12/2003 - 05/2002
2anandamide (arachidonylethanolamide)IBA
12/2003 - 03/2002
1Macrophage Colony-Stimulating FactorIBA
01/2022
1CytokinesIBA
01/2022
1ChemokinesIBA
01/2022
1salicylhydroxamic acid (SHAM)IBA
01/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2022
1Cannabinoid Receptor AgonistsIBA
01/2021
1Monoacylglycerol LipasesIBA
01/2021
1PPAR alphaIBA
01/2021
1mesoglycanIBA
01/2021
1CannabidiolIBA
01/2021
1Medical MarijuanaIBA
01/2020
1PlasticsIBA
01/2020
1Pain-FreeIBA
11/2019
1Duloxetine Hydrochloride (Cymbalta)FDA Link
11/2018
1HIV Protease InhibitorsIBA
01/2017
1Indinavir (Crixivan)FDA Link
01/2017
1Angiotensin IIIBA
02/2016
1Fatty Acids (Saturated Fatty Acids)IBA
01/2016
1AmidesIBA
01/2016
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2015
1Lidocaine (Xylocaine)FDA LinkGeneric
02/2015
1Tramadol (K315)FDA LinkGeneric
02/2015
1Serotonin (5 Hydroxytryptamine)IBA
02/2015
1Opioid Analgesics (Opioids)IBA
02/2015
1Type A Botulinum Toxins (Botox)FDA Link
02/2015
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
02/2015
1Norepinephrine (Noradrenaline)FDA LinkGeneric
02/2015
1Explosive Agents (Explosives)IBA
11/2014
1Triglycerides (Triacylglycerol)IBA
09/2014
1Type 1 Angiotensin ReceptorIBA
04/2014
1Interleukin-6 (Interleukin 6)IBA
01/2014

Therapy/Procedure

15Therapeutics
01/2022 - 07/2005
10Pain Management
01/2022 - 08/2008
8Drug Therapy (Chemotherapy)
01/2020 - 10/2009
5Analgesia
01/2021 - 01/2011
2Intravenous Injections
01/2017 - 04/2013
2Injections
10/2016 - 10/2016
1Spinal Cord Stimulation
01/2022
1Length of Stay
01/2022
1Duration of Therapy
01/2021
1Ambulatory Care (Outpatient Care)
12/2018
1Precision Medicine
09/2016
1Surgical Amputation (Amputations)
11/2014
1Ligation
11/2013